Astrazeneca Pharma India Debt 2024

Debt Details

Understanding Astrazeneca Pharma India's Debt Structure

Astrazeneca Pharma India's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Astrazeneca Pharma India's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Astrazeneca Pharma India’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Astrazeneca Pharma India’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Astrazeneca Pharma India Stock

What is the debt of Astrazeneca Pharma India this year?

Astrazeneca Pharma India has a debt level of 0 INR this year.

What was the debt of Astrazeneca Pharma India compared to the previous year?

The debt of Astrazeneca Pharma India has increased by -100% compared to the previous year dropped.

What are the consequences of high debt for investors in Astrazeneca Pharma India?

High debt can pose a risk for investors of Astrazeneca Pharma India, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Astrazeneca Pharma India?

Low debt means that Astrazeneca Pharma India has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Astrazeneca Pharma India affect the company?

An increase in debt of Astrazeneca Pharma India can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Astrazeneca Pharma India affect the company?

A reduction in debt of Astrazeneca Pharma India can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Astrazeneca Pharma India?

Some factors that can influence the debt of Astrazeneca Pharma India include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Astrazeneca Pharma India so important for investors?

The debts of Astrazeneca Pharma India are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Astrazeneca Pharma India take to change the debt?

To change the debt, Astrazeneca Pharma India can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Astrazeneca Pharma India pay?

Over the past 12 months, Astrazeneca Pharma India paid a dividend of 16 INR . This corresponds to a dividend yield of about 0.25 %. For the coming 12 months, Astrazeneca Pharma India is expected to pay a dividend of 16 INR.

What is the dividend yield of Astrazeneca Pharma India?

The current dividend yield of Astrazeneca Pharma India is 0.25 %.

When does Astrazeneca Pharma India pay dividends?

Astrazeneca Pharma India pays a quarterly dividend. This is distributed in the months of September, September, August, August.

How secure is the dividend of Astrazeneca Pharma India?

Astrazeneca Pharma India paid dividends every year for the past 0 years.

What is the dividend of Astrazeneca Pharma India?

For the upcoming 12 months, dividends amounting to 16 INR are expected. This corresponds to a dividend yield of 0.25 %.

In which sector is Astrazeneca Pharma India located?

Astrazeneca Pharma India is assigned to the 'Health' sector.

Wann musste ich die Aktien von Astrazeneca Pharma India kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Astrazeneca Pharma India from 9/13/2023 amounting to 16 INR, you needed to have the stock in your portfolio before the ex-date on 7/14/2023.

When did Astrazeneca Pharma India pay the last dividend?

The last dividend was paid out on 9/13/2023.

What was the dividend of Astrazeneca Pharma India in the year 2023?

In the year 2023, Astrazeneca Pharma India distributed 8 INR as dividends.

In which currency does Astrazeneca Pharma India pay out the dividend?

The dividends of Astrazeneca Pharma India are distributed in INR.